Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hexokinase is an enzyme that phosphorylates hexoses, forming hexose-6-phosphate. In most tissues, glucose is the most important substrate, and the product is glucose-6-phosphate (G6P), the first step in glycolysis. There are four main mammalian isoforms (HK-I, HK-II, HK-III, and glucokinase/HK-IV), each with distinct tissue distribution, regulatory properties, and roles in glucose metabolism and insulin secretion. Dysregulation of hexokinase activity is implicated in various diseases, including cancer and diabetes.
Catalyzes the phosphorylation of hexoses (primarily glucose) to glucose-6-phosphate, initiating glycolysis. Glucokinase acts as a glucose sensor in pancreatic beta cells, regulating insulin secretion based on blood glucose levels.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hexokinase (HK).